Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-α
- 31 December 1994
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (9) , 1310-1314
- https://doi.org/10.1016/0959-8049(94)90179-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2Annals of Oncology, 1992
- Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: Results of a European multi-center phase III studyAnnals of Oncology, 1992
- Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.Journal of Clinical Oncology, 1992
- Long-term results in patients with metastatic renal cell carcinoma treated with interferon with or without vinblastineWorld Journal of Urology, 1991
- Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases.Journal of Clinical Oncology, 1991
- Prognostic factors of adult metastatic renal carcinoma: A multivariate analysisSeminars in Surgical Oncology, 1988